SNDLNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
SNDL Inc.
Financials through fiscal 2026, year ended Dec 31, 2025Last filing: 40-F on Mar 12, 2026
$1.25+0.00 (+0.40%)
Close on Oct 19, 2026
SNDL Inc. income statement
Ratios
Latest available, balances at Dec 31, 2025
Profitability, FY2026
- Gross margin
- 27.3%
- Operating margin
- -0.7%
- Net margin
- -1.7%
- Return on equity, FY2026
- -1.4%
Financial strength
- Current ratio
- 4.88
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 273.6%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
Valuation ratios need the share price and fill in once daily prices are connected.